NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Acurx Pharmaceuticals Inc. Common Stock (NASDAQ: ACXP)
ACXP Technical Analysis
5
As on 9th Jun 2023 ACXP STOCK Price closed @ 2.81 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.62 & Strong Sell for SHORT-TERM with Stoploss of 4.12 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACXPSTOCK Price
Open | 2.83 | Change | Price | % |
High | 3.01 | 1 Day | -0.01 | -0.35 |
Low | 2.78 | 1 Week | -0.09 | -3.10 |
Close | 2.81 | 1 Month | -0.25 | -8.17 |
Volume | 39977 | 1 Year | -1.62 | -36.57 |
52 Week High 4.78 | 52 Week Low 2.42 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ACXP Daily Charts |
ACXP Intraday Charts |
Whats New @ Bazaartrend |
ACXP Free Analysis |
|
ACXP Important Levels Intraday
RESISTANCE | 3.25 |
RESISTANCE | 3.11 |
RESISTANCE | 3.02 |
RESISTANCE | 2.94 |
SUPPORT | 2.68 |
SUPPORT | 2.60 |
SUPPORT | 2.51 |
SUPPORT | 2.37 |
ACXP Forecast May 2024
4th UP Forecast | 6.16 |
3rd UP Forecast | 5.09 |
2nd UP Forecast | 4.42 |
1st UP Forecast | 3.76 |
1st DOWN Forecast | 1.86 |
2nd DOWN Forecast | 1.2 |
3rd DOWN Forecast | 0.53 |
4th DOWN Forecast | -0.54 |
ACXP Weekly Forecast
4th UP Forecast | 3.85 |
3rd UP Forecast | 3.52 |
2nd UP Forecast | 3.31 |
1st UP Forecast | 3.10 |
1st DOWN Forecast | 2.52 |
2nd DOWN Forecast | 2.31 |
3rd DOWN Forecast | 2.10 |
4th DOWN Forecast | 1.77 |
ACXP Forecast2024
4th UP Forecast | 7.74 |
3rd UP Forecast | 6.16 |
2nd UP Forecast | 5.18 |
1st UP Forecast | 4.21 |
1st DOWN Forecast | 1.41 |
2nd DOWN Forecast | 0.44 |
3rd DOWN Forecast | -0.54 |
4th DOWN Forecast | -2.12 |
Acurx Pharmaceuticals Inc. Common Stock ( NASDAQ USA Symbol : ACXP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACXP Other Details
Segment | EQ | |
Market Capital | 50899580.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ACXP Address
ACXP Latest News
ACXP Business Profile
Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York. Address: 259 Liberty Avenue, Staten Island, NY, United States, 10305
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service